Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.43% |
| 2 | Energy | 4.72% |
| 3 | Technology | 4.42% |
| 4 | Financials | 3.4% |
| 5 | Consumer Discretionary | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMS
2526
DELISTED
Bemis
BMS
| $2.16M | ﹤0.01% |
56,958
-17,807
| -24% | -$709K |
|
2527
CALL
MBIA
MBI
$257M
| $2.16M | ﹤0.01% |
240,100
+179,200
| +294% | +$1.76M |
|
2528
United Therapeutics
UTHR
$22.5B
| $2.16M | ﹤0.01% |
16,863
-58,490
| -78% | -$6.03M |
|
2529
Vermilion Energy
VET
$1.74B
| $2.15M | ﹤0.01% |
35,929
+15,073
| +72% | +$964K |
|
|
XLS
2530
DELISTED
EXELIS INC COM STK
XLS
| $2.15M | ﹤0.01% |
134,677
-80,128
| -37% | -$1.3M |
|
2531
SEI Investments
SEIC
$12.7B
| $2.15M | ﹤0.01% |
59,793
+3,703
| +7% | +$132K |
|
|
APLP
2532
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
| $2.15M | ﹤0.01% |
74,289
+41,953
| +130% | +$1.21M |
|
|
SOHU
2533
PUT
Sohu.com
SOHU
$378M
| $2.15M | ﹤0.01% |
43,000
-14,300
| -25% | -$808K |
|
|
PF
2534
DELISTED
Pinnacle Foods, Inc.
PF
| $2.14M | ﹤0.01% |
66,957
-746,266
| -92% | -$23.6M |
|
|
PKY
2535
DELISTED
Parkway, Inc.
PKY
| $2.14M | ﹤0.01% |
118,929
-165,243
| -58% | -$3.38M |
|
2536
JD.com
JD
$43.1B
| $2.14M | ﹤0.01% |
+85,400
| New | +$2.46M |
|
|
ISIL
2537
DELISTED
Intersil Corp
ISIL
| $2.14M | ﹤0.01% |
152,683
+38,161
| +33% | +$554K |
|
2538
Ultrapar
UGP
$6.34B
| $2.14M | ﹤0.01% |
203,350
+50,856
| +33% | +$603K |
|
|
STJ
2539
PUT
DELISTED
St Jude Medical
STJ
| $2.13M | ﹤0.01% |
35,500
+20,700
| +140% | +$1.35M |
|
|
FSL
2540
PUT
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $2.13M | ﹤0.01% |
112,000
-56,700
| -34% | -$1.21M |
|
2541
Middleby
MIDD
$5.5B
| $2.12M | ﹤0.01% |
24,134
-39,205
| -62% | -$3.25M |
|
|
RDC
2542
DELISTED
Rowan Companies Plc
RDC
| $2.12M | ﹤0.01% |
84,922
-115,402
| -58% | -$3.4M |
|
|
ARUN
2543
PUT
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $2.12M | ﹤0.01% |
101,100
-9,200
| -8% | -$181K |
|
|
MMP
2544
CALL
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $2.12M | ﹤0.01% |
25,200
-17,100
| -40% | -$1.42M |
|
2545
CALL
AB InBev
BUD
$159B
| $2.11M | ﹤0.01% |
19,200
+6,300
| +49% | +$704K |
|
|
MWE
2546
PUT
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $2.11M | ﹤0.01% |
27,800
-4,800
| -15% | -$359K |
|
|
CHL
2547
DELISTED
China Mobile Limited
CHL
| $2.11M | ﹤0.01% |
36,378
+8,855
| +32% | +$510K |
|
|
WNR
2548
DELISTED
Western Refining Inc
WNR
| $2.1M | ﹤0.01% |
51,394
-8,643
| -14% | -$373K |
|
|
PETX
2549
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.1M | ﹤0.01% |
210,287
+209,765
| +40,185% | +$2.54M |
|
2550
Gerdau
GGB
$9.25B
| $2.1M | ﹤0.01% |
660,495
-282,589
| -30% | -$1.29M |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.